Please assess the completion status of the following clinical trial:

Trial Title: Effect of Iranian Traditional Medicine Remedy on Chemotherapy Induced Nausea and Vomiting

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria:~* Clinical diagnosis of breast cancer,~* Clinical diagnosis of chemotherapy induced nausea and vomiting resistant to conventional therapy.~Exclusion Criteria:~* Clinical diagnosis of hypersensitivity to Sumac or Bunium Persicum,~* Clinical diagnosis of digestion disorders,~* Clinical diagnosis of non chemotherapy induced nausea and vomiting,~* Milk allergy,~* Clinical diagnosis of bleeding diathesis,~* Clinical diagnosis of non-breast cancer.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- intervention (Type: ACTIVE_COMPARATOR): 2.7 grams Persumac powder (Iranian traditional medicine remedy composed from sumac and Bunium Persicum) every 8 hour from 24 hour before to fifth day after chemotherapy.
- control (Type: PLACEBO_COMPARATOR): 2.7 grams Lactose every 8 hour from 24 hour before to fifth day after chemotherapy.

Based on this trial design, predict the completion outcome and termination type (if applicable).